Advancing Drug Discovery Projects more Efficiently from Bench to Bedside

Less time better results

The Experimental and Preclinical Imaging Core provides investigators with the ability to optimize drug treatments in small animals and cell lines, including both small molecule and nanoparticle drug delivery.  The capabilities of the near-infrared and bioluminescence imaging services are compatible with most small animal models. These services allow investigators the opportunity for in vivo target validation and dynamic analysis of mechanism of action of novel molecular therapeutics which will advance drug discovery projects more efficiently from bench to bedside. In addition, investigators will learn more about the molecular mechanisms associated with different diseases.


One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
23rd nationwide for service to veterans —"Best for Vets," Military Times
KU Today